PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemiaZhaohui Gu, Williams E. Evans, Stanley Pounds et al.|Nature Genetics|2019Cited by 616
The genomic landscape of pediatric acute lymphoblastic leukemiaSamuel W. Brady, Richard C. Harvey, Kathryn G. Roberts et al.|Nature Genetics|2022Cited by 394
Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children’s Oncology Group study AALL0232Michael J. Borowitz, Eric Larsen, Brent L. Wood et al.|Blood|2015Cited by 356
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children’s Oncology GroupShalini C. Reshmi, Stephen P. Hunger, Richard C. Harvey et al.|Blood|2017Cited by 305
Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALLBrent L. Wood, Ilan Kirsch, David Wu et al.|Blood|2017Cited by 227